Evidence map›Paper›PMID 39386703›Full record

ArticlebioRxiv : the preprint server for biology2024

A one-step protocol to generate impermeable fluorescent HaloTag substrates for

Kilian Roßmann, Siqi Sun, Christina Holmboe Olesen, Maria Kowald, Eleni Tapp, Ulrich Pabst, Marie Bieck, Ramona Birke, Brenda C Shields, PyeongHwa Jeong and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Kilian RoßmannLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.ORCID 0000-0003-4965-9669
Siqi SunLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.ORCID 0009-0002-8291-3358
Christina Holmboe OlesenLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.ORCID 0000-0002-0575-1597
Maria KowaldLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.ORCID 0009-0001-4769-4834
Eleni TappLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.ORCID 0009-0005-6277-7813
Ulrich PabstLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.ORCID 0009-0007-0529-0720
Marie BieckLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.
Ramona BirkeLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.
Brenda C ShieldsDuke University, Department of Biomedical Engineering, Durham, North Carolina 27708, USA.ORCID 0000-0001-9036-2686
PyeongHwa JeongDuke University, Department of Chemistry, Durham, North Carolina 27708, USA.ORCID 0009-0000-3796-7627
Jiyong HongDuke University, Department of Chemistry, Durham, North Carolina 27708, USA.ORCID 0000-0002-5253-0949
Michael R TadrossDuke University, Department of Biomedical Engineering, Durham, North Carolina 27708, USA.ORCID 0000-0002-7752-6380
Joshua LevitzWeill Cornell Medicine, Department of Biochemistry, NY, USA.ORCID 0000-0002-8169-6323
Martin LehmannLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.ORCID 0000-0002-8370-6353
Noa LipsteinLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.ORCID 0000-0002-0755-5899
Johannes BroichhagenLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), 13125 Berlin, Germany.ORCID 0000-0003-3084-6595

Funding

DART.3-Revolutionizing Neuropsychiatric Treatment through Noninvasive, Programmable Cell-Type-Specific NeuropharmacologyR01MH135932 · NIMH · DUKE UNIVERSITY · PI Michael R Tadross · 2024 to 2026
$4.4M
DART2.0: comprehensive cell type-specific behavioral neuropharmacologyRF1MH117055 · NIMH · DUKE UNIVERSITY · PI TADROSS, MICHAEL R · 2018 to 2018
$3.8M
Mechanisms of Regulation of Metabotropic Glutamate ReceptorsR01NS129904 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Joshua Levitz · 2023 to 2026
$2.6M
NIMH NIH HHS R01 MH135932NIMH NIH HHS RF1 MH117055NINDS NIH HHS R01 NS129904
6 · The paper itself

Abstract

Communication between cells is largely orchestrated by proteins on the cell surface, which allow information transfer across the cell membrane. Super-resolution and single-molecule visualization of these proteins can be achieved by genetically grafting HTP (HaloTag Protein) into the protein of interest followed by brief incubation of cells with a dye-HTL (dye-linked HaloTag Ligand). This approach allows for use of cutting-edge fluorophores optimized for specific optical techniques or a cell-impermeable dye-HTL to selectively label surface proteins without labeling intracellular copies. However, these two goals often conflict, as many high-performing dyes exhibit membrane permeability. Traditional methods to eliminate cell permeability face synthetic bottlenecks and risk altering photophysical properties. Here we report that dye-HTL reagents can be made cell-impermeable by inserting a charged sulfonate directly into the HTL, leaving the dye moiety unperturbed. This simple, one-step method requires no purification and is compatible with both the original HTL and second-generation HTL.2, the latter offering accelerated labeling. We validate such compounds, termed dye-SHTL ('dye shuttle') conjugates, in live cells via widefield microscopy, demonstrating exclusive membrane staining of extracellular HTP fusion proteins. In transduced primary hippocampal neurons, we label mGluR2, a neuromodulatory G protein-coupled receptor (GPCR), with dyes optimized for stimulated emission by depletion (STED) super-resolution microscopy, allowing unprecedented accuracy in distinguishing surface and receptors from those in internal compartments of the presynaptic terminal, important in neural communication. This approach offers broad utility for surface-specific protein labelling.

Indexed as

ATTO 647Nfluorescence microscopyHaloTagimpermeabilitymGluR2STED

Identifiers

PMID39386703
PMCPMC11463609

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.